HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2024 |
07/01/2024 - 4:00pm to 5:00pm EDT |
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2024 |
07/08/2024 - 4:00pm to 5:00pm EDT |
MRD+ After Frontline Fixed Duration Venetoclax and Obinutuzumab: What Now? |
05/13/2024 - 4:00pm to 5:00pm EDT |
MyeloMATCH: An NCTN precision medicine initiative for the evaluation of novel therapies in patients with newly diagnosed AML and MDS |
03/11/2024 - 4:00pm to 5:00pm EDT |
Point-of-care Manufacturing of Cell therapies: Opportunities and Challenges |
05/06/2024 - 4:00pm to 5:00pm EDT |
Primary CNS Lymphoma: Present and Future |
03/04/2024 - 4:00pm to 5:00pm EST |
Targeting Bone Marrow Endothelial Niche-Derived Paracrine Factors in Multiple Myeloma |
05/20/2024 - 4:00pm to 5:00pm EDT |
The Role of Autologous Transplantation in the Management of Mantle Cell Lymphoma |
04/08/2024 - 4:00pm to 5:00pm EDT |
The Treatment of Diffuse Large B Cell Lymphoma: Sine Waves and Harmonics |
01/08/2024 - 4:00pm to 5:00pm EST |
Therapeutic Targeting of STAT3 in Myeloid Malignancies |
04/22/2024 - 4:00pm to 5:00pm EDT |